Success of Intralesional Purified Protein Derivative Immunotherapy in the Treatment of Anogenital Warts: A Case Report
Pati Aji Achdiat,1 Narizka Civiadenta Antariksa,1 Rasmia Rowawi,1 Oki Suwarsa,1 Yudi Mulyana Hidayat,2 Reiva Farah Dwiyana,1 Hendra Gunawan,1 Reti Hindritiani1 1Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran-Dr.Hasan Sadikin Hospital, Bandung, West Java, Indo...
Main Authors: | Achdiat PA, Antariksa NC, Rowawi R, Suwarsa O, Hidayat YM, Dwiyana RF, Gunawan H, Hindritiani R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-04-01
|
Series: | Journal of Experimental Pharmacology |
Subjects: | |
Online Access: | https://www.dovepress.com/success-of-intralesional-purified-protein-derivative-immunotherapy-in--peer-reviewed-fulltext-article-JEP |
Similar Items
-
Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article
by: Achdiat PA, et al.
Published: (2024-03-01) -
Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus
by: Pati Aji Achdiat, et al.
Published: (2024-01-01) -
Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report
by: Pati Aji Achdiat, et al.
Published: (2023-01-01) -
Intralesional immunotherapy for the treatment of anogenital warts in pediatric population
by: Ahmad Nofal, et al.
Published: (2022-02-01) -
Efficacy and safety of treating anogenital warts with intralesional vitamin D3 injection: a report on 20 Egyptian patients
by: Yasmin M Tawfik, et al.
Published: (2020-01-01)